Dissertation > Excellent graduate degree dissertation topics show

Diagnostic Utility of Serum and Pleural Fluid Tumor Markers (Cyfra 21-1,CEA, NSE, SCC) in Patients with Pleural Effusions from Primary Lung Cancer

Author: Gopall Roshnee
Tutor: Professor Chen Hong（ChenHong）
School: Chongqing Medical University
Course:
Keywords: carcinoembryonic antigen cytokeratin 19 fragments lung cancer neuron-specific enolase squamous cell carcinoma pleural effusion
CLC: R734.2
Type: Master's thesis
Year: 2011
Downloads: 7
Quote: 0
Read: Download Dissertation

Abstract


Study objective: To assess the diagnostic values of cytokeratin 19 fragments (CYFRA 21–1), carcinoembryonic antigen (CEA), neuron-specific enolase (NSE) and squamous cell carcinoma antigen (SCC) as markers of pleurisy in primary lung cancer and as an aid in histological diagnosis.Design: Analysis of four tumor markers in serum and pleural fluid with a confirmatory diagnosis of malignancy by pleural cytology or material obtained during bronchoscopy.Setting: The First Affiliated Hospital of Chongqing Medical University, Department of PulmonologyPatients and Methods: Data was collected from the case sheets of patients admitted in hospital with a preliminary diagnosis of pleural effusion during the period of January 2010 to July 2010. A total of 37 patients with malignant effusions and 23 patients with benign effusions were enrolled. Levels of CEA, CYFRA 21–1, NSE, and SCC were measured in the serum and pleural fluid of these patients.Results: Patients with lung cancer were found to have significantly higher levels of CEA, CYFRA 21–1, NSE and SCC than those in the benign group. The serum tumor marker with the highest sensitivity for malignancy was CYFRA 21–1 (86.49%), whereas serum NSE had the highest specificity (95.65%).In pleural fluid, CYFRA 21-1 had the highest sensitivity (97.3%),whereas CEA had the highest specificity (91.3%) and accuracy of 83.33%. When combinations of tumor markers were evaluated, CEA and CYFRA 21-1 gave a high diagnostic performance in both serum and pleural fluid. Moreover, the sensitivity of all the studied markers was relatively higher in pleural fluid than in serum. The use of these biomarkers could also suggest the histological diagnosis in the malignant group: CEA in adenocarcinoma, SCC in squamous cell carcinoma and NSE in SCLC.Conclusions: In our study, significant differences between the serum and pleural fluid samples, as well as between the malignant and benign forms of pleural effusion were noted. CYFRA 21-1 proved to be the single and most sensitive tumor marker and its combination with CEA could enhance its diagnostic yield. SCC and NSE can be considered as useful parameters in the screening of squamous cell carcinoma and SCLC respectively. In our study, the use of our tumor marker panel has shown a clear relationship with histological subtype.

Related Dissertations

  1. The Clinical Research for the Effect of Iodine-125 Seeds Implanted in Advanced Bronchial Lung Cancer,R734.2
  2. Effects of 5-Aza-2-deoxycytidine on DNA Methylation and Expression of p16 and MGMT Gene in Lung Cancer Cell Line SPC-A-1,R734.2
  3. The Clinical Value of Detection of Serum TPS, CEA, CYFRA21-1, NSE for Diagnosis in Patients with Lung Cancer,R734.2
  4. Expression of MMP-9 and p63 in Oral Squamous Cell Carcinoma and Clinical Significance,R739.8
  5. Study on the Expression and Correlation of Metallothionein and Matrix Metalloproteinase-2 in Non-small Cell Lung Cancer,R734.2
  6. The Effect of RNA Interference-mediated ERCC1 Gene on the Chemo-treatment Sensitivity of NSCLC in Vitro,R734.2
  7. The Experimental Study of Semiconductor Laser Radiation and 5-FU Sustained Release Repressed Oral Malignant Tumor Cell,R739.8
  8. Non-small Cell Lung Cancer Analysis of 133 Cases of CVATS Lobectomy,R734.2
  9. Clinical Observation of Pemetrexed for Treating Advanced Non-small Cell Lung Cancer,R734.2
  10. Exploreing the Mechanism of Xieshifeiaifang Ii on Treating Lung Cancer with Pleura Effusion,R734.2
  11. Expression of Chemokine Receptor CCR5 in Human Non-small-cell Lung Cancer,R734.2
  12. Influences of Cisplatin on Expressions of P-glycoprotein in the Resistance Cells of in Lung Cancer Xenografts in the Mice,R734.2
  13. Effect of Rh-Endostatin on the Expression of ERCC1 in Human Lung Adenocarcinoma A549 Cells,R734.2
  14. The Investigation of Relationship between Therapeutic Effect and Prognosis and Changes of Peripheral Blood Vascular Endothelial Growth Factor and Metallothionein in Patients with Advanced Lung Cancer,R734.2
  15. Association of Expression of ERCC1/RRM1 with Survival and Resistance to Platinum Inpatients with Ⅰ-ⅢA NSCLC,R734.2
  16. Expression and Prognostic Significance of TS and BRCAl mRNA in Non-small Cell Lung Cancer,R734.2
  17. Clinical Study on Effect of Xie Shi Lung Cancer NO.2 in Malignant Pleural Effusion of Lung Cancer,R734.2
  18. MMP-2, VEGF, CD105, Ki67 in small cell lung carcinoma and prognosis of,R734.2
  19. Experimental Studies on Therapy of Lung Cancer by VEGF-C siRNA Mediated by Liposomes,R734.2
  20. The Role and Mechanism of SDF-1/CXCR4 Axis in Small Cell Lung Cancer Invasion and Metastasis,R734.2
  21. Mechanisms of Inactivation of PETN by Carchnoqen Benzo(a) Pyrene,R730.2

CLC: > Medicine, health > Oncology > Respiratory system tumors > Lung tumors
© 2012 www.DissertationTopic.Net  Mobile